Putri Vanesia Sihombing

Strategic Performances & Initiatives Assistant Manager at COMBIPHAR

Putri Vanesia Sihombing is a seasoned professional in the pharmaceutical industry with a strong background in quality assurance and risk management. Currently serving as Risk Management Assistant Manager at COMBIPHAR since March 2020, Putri has also held positions as Assistant QA Manager and Quality Assurance Change Control Supervisor. Prior experience includes working as a QA Supervisor at PT Kalbe Farma, Tbk, where Putri managed a team of inspectors focused on IPC and deviation handling. Additional internships at Balai Besar POM Jakarta and PT Corsa Industries provided valuable experience in consumer certification and research and development. Putri holds a Bachelor's degree in Pharmaceutical Sciences and an Apt degree in Industrial and Physical Pharmacy and Cosmetic Sciences from Institut Teknologi Bandung.

Location

West Java, Indonesia

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


COMBIPHAR

1 followers

Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.